Vanguard Portfolio Management
CHRS icon

Vanguard Portfolio Management’s Coherus Oncology CHRS Stock Holding History

Vanguard Portfolio Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.24M Buy
883,454
+278,929
+46% +$455K ﹤0.01% 2898
2026
Q1 		$1.02M Buy
+604,525
New +$1.07M ﹤0.01% 2793

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Vanguard Portfolio Management's CHRS Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Coherus Oncology (CHRS) stake by 46% in Q2 2026, buying an estimated $455K and bringing the position to 883,454 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2898.

Vanguard Portfolio Management first reported a position in CHRS in Q1 2026 and has held it in 2 quarters since. 145 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • Vanguard Portfolio Management held 883,454 shares of Coherus Oncology worth $1.24M as of Q2 2026.
  • Vanguard Portfolio Management bought 278,929 Coherus Oncology shares in Q2 2026, an estimated $455K.
  • Coherus Oncology made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2898 holding.
  • Vanguard Portfolio Management first reported a position in Coherus Oncology in Q1 2026 and has held it in 2 quarters since.
  • 145 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.